Search Abstracts Program


Session 37   Poster Presentations
RNAi, Lentvirus Vectors, and Gene-Based Therapy
Tuesday 1:30 - 3:30 pm
Hall D
220Modulating the HIV-1 Replication Cycle Through RNAi
Jean-Marc Jacque*, Mario Stevenson
Prgm in Molecular Med, Univ of Massachusetts Med Sch, Worcester, MA, USA, 01605
221RNA Interference of Chemokine Receptor Expression Allows for Inhibition of HIV-1 Replication
MA Martinez1, A Gutierrez1, M Armand-Ugon1, J Blanco1, M Parera1, J Gomez2, B Clotet1, J.A. Este*1
1Fundacio IrsiCaixa, Barcelona, Spain and 2Hosp Vall d'Hebron, Barcelona, Spain
222CXCR4 Gene Silencing with Multiple Small Interfering RNAs Inhibits HIV-1 Infection
J. Ji*, P. Erb, T. Klimkait, M. Wernli
Inst Med Microbiology, Basel, Switzerland
223Inhibition of CCR5 Expression Using RNA Interference Selectively Blocks Infection by R5-Tropic HIV-1
M. T. M Lee*, B. R. Cullen
Howard Hughes Med Inst (HHMI) and Duke Univ Med Ctr, Durham, NC
224Silencing Gene Expression by Short Interfering RNA Targeting NF-kB Binding Site within 5’ LTR
K Suzuki*1, S Suter2, R Ward2, D Cooper3, A Kelleher3
1Ctr for Immunology, St Vincent's Hosp, Daringhurst, Australia; 2Med Oncology, St Vincent’s Hosp, Australia; and 3Natl Ctr for HIV Epidemiological and Clin Res, Sydney, Australia
225Sustained siRNA-mediated HIV Inhibition in Primary Macrophages
P. Shankar*1, E. Song1, S.K. Lee1, D.M. Dykxhoom2, C. Novina2, K. Crawford1, J. Cerny1, P.A. Sharp2, J. Lieberman1, M.N. Swamy1
1Ctr for Blood Res, Harvard Med Sch, Boston, MA and 2Ctr for Cancer Res, MIT, Cambridge, MA
226Combination Therapies Targeting CCR5 Using RNAi, Antibody, and Ribozymes Delivered by rSV40 Vectors
Pierre Cordelier*1, Barry A. Morse Jr1, Joseph Kukowski1, Mohammad BouHamdan1, Roger J. Pomerantz 1, John Rossi2, David S. Strayer1
1Jefferson Med Coll, Philadelphia, PA and 2City of Hope, Beckman Inst, Duarte, CA
227Lentiviral Vectors Interfering with CD4 Down-modulation as an Anti-HIV Approach
B. Gröschel*, M.J. Cortés, E. Argańaraz, J. Lama
Univ of California at San Diego, La Jolla
228Lentivirus Packaging and Gene Transfer Vectors
S. K. Arya*, J. E. Cho, A. Zamani
Natl Cancer Inst, NIH, Bethesda, MD
229The HIV-1 cPPT/CTS Fragment Mediates Efficient Transgene Expression from Lentiviral Vectors
J van Griensven*, B Van Maele, E De Clercq, Z Debyser
Rega Inst for Med Res, Katholieke Univ Leuven, Belgium
230A Comprehensive Approach to Gene Therapy of HIV Infection
J. van Lunzen*1, G. Brandenburg2, C. Baum3, M. Egelhofer4, K. Kühlcke4, H. Martinius5, P. Schult-Dietrich5, F. Vorpahl5, A. Alexandrov5, D. von Laer2
1Univ Hosp Eppendorf, Hamburg, Germany; 2Georg-Speyer-Haus, Frankfurt, Germany; 3Med Hochschule Hannover, Germany; 4Eufets AG, Idar-Oberstein, Germany; and 5Fresenius HemoCare, Martinsried, Germany
231Biological Therapy of HIV/AIDS Using HIV-based Vectors Containing Anti-HIV Genetic Payloads
B. Dropulic*1,2, L. Humeau1, X. Lu1, V. Slepushkin1, B. Levine3, Q. Yu1, Y. Ni1, B. Davis1, R. Carroll3, Y. Chang1, C. June3
1VIRxSYS Corp, Gaithersburg, MD; 2Kimmel Cancer Ctr at Johns Hopkins, Johns Hopkins Univ Sch of Med, Baltimore, MD; and 3Abramson Family Cancer Res Inst, Univ of Pennsylvania, Philadelphia
231aInhibition of HIV Infection in CD4 T-cells by Lentiviral-mediated Delivery of anti-CCR5 siRNA is Influenced by CCR5 Expression
C. Butticaz1, A. Ciuffi1, M. Munoz1, J. Thomas1, R. Iggo2, P. Meylan1, A. Telenti*1
1Infectious Diseases and Microbiology, CHUV, Lausanne, Switzerland and 2Swiss Cancer Research Institute, Epalinges, Switzerland
231bEfficient Inhibition of HIV-1 Replication by RNA Interference
Thijn R. Brummelkamp1, Atze T. Das2, Monique Vink2, René Bernards1, Ben Berkhout*2
1Dutch Cancer Institute, Amsterdam, the Netherlands and 2AMC, University of Amsterdam, the Netherlands
231cInhibition of HIV-1 Replication by Stable Cellular Expression of tat –Specific Short Interfering RNA.
Daniel Boden*, Oliver Pusch, Frederick Lee, Lynne Tucker, Peter Shank, Bharat Ramratnam
Brown Medical School, Providence, RI, USA